OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
416159

BinDawood Holding Company SJSC

Food Retail & DistributionVerified

The company maintains a debt-to-equity ratio of 1.85, indicating a relatively high leverage position compared to industry norms. Its liquidity position is characterized as medium, with a current ratio of 1.17, suggesting limited short-term liquidity cushion. The company's return on equity (ROE) is 17.64%, which is strong relative to the industry median, while its return on assets (ROA) is 4.4%, indicating moderate asset efficiency. Profitability metrics show a gross profit of SAR 2.17 billion and operating income of SAR 395.7 million, translating to a gross margin of 34.1% and an operating margin of 6.2%. These figures are in line with the industry's preferred metrics, though the operating margin is slightly below the median for the Food Retail & Distribution sector. The company's net income of SAR 269.9 million reflects a net margin of 4.25%, which is consistent with the sector's performance. The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification beyond Saudi Arabia. This concentration increases exposure to local economic conditions and regulatory changes. The company's capital structure is dominated by long-term debt, which accounts for SAR 2.83 billion, or 46% of total liabilities. Looking ahead, the company is projected to grow revenue by 4.5% in the current fiscal year and 3.2% in the next, based on analyst estimates and historical performance. Free cash flow of SAR 465.1 million supports reinvestment and shareholder returns, though capital expenditures of SAR 161.4 million suggest ongoing investment in infrastructure. The company's risk profile is moderate, with a low dilution risk and a liquidity risk score of medium. Recent filings and transcripts indicate a focus on expanding digital retail capabilities and optimizing supply chain logistics. The company has not disclosed any material regulatory or geopolitical risks in its latest reports, though the Food Retail & Distribution industry is sensitive to inflation and supply chain disruptions.

30-day price · 4161-0.20 (-3.9%)
Low$4.80High$5.47Close$4.93As of21 May, 00:00 UTC
Profile
CompanyBinDawood Holding Company SJSC
Ticker4161.SE
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. BinDawood Holding Company SJSC operates in the Food & Drug Retailing sector, generating revenue primarily through the retail and distribution of food and drug products.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

The company maintains a debt-to-equity ratio of 1.85, indicating a relatively high leverage position compared to industry norms. Its liquidity position is characterized as medium, with a current ratio of 1.17, suggesting limited short-term liquidity cushion. The company's return on equity (ROE) is 17.64%, which is strong relative to the industry median, while its return on assets (ROA) is 4.4%, indicating moderate asset efficiency. Profitability metrics show a gross profit of SAR 2.17 billion and operating income of SAR 395.7 million, translating to a gross margin of 34.1% and an operating margin of 6.2%. These figures are in line with the industry's preferred metrics, though the operating margin is slightly below the median for the Food Retail & Distribution sector. The company's net income of SAR 269.9 million reflects a net margin of 4.25%, which is consistent with the sector's performance. The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification beyond Saudi Arabia. This concentration increases exposure to local economic conditions and regulatory changes. The company's capital structure is dominated by long-term debt, which accounts for SAR 2.83 billion, or 46% of total liabilities. Looking ahead, the company is projected to grow revenue by 4.5% in the current fiscal year and 3.2% in the next, based on analyst estimates and historical performance. Free cash flow of SAR 465.1 million supports reinvestment and shareholder returns, though capital expenditures of SAR 161.4 million suggest ongoing investment in infrastructure. The company's risk profile is moderate, with a low dilution risk and a liquidity risk score of medium. Recent filings and transcripts indicate a focus on expanding digital retail capabilities and optimizing supply chain logistics. The company has not disclosed any material regulatory or geopolitical risks in its latest reports, though the Food Retail & Distribution industry is sensitive to inflation and supply chain disruptions.
Key takeaways
  • The company maintains a strong ROE of 17.64% but operates with a high debt-to-equity ratio of 1.85.
  • Revenue is concentrated in the Food & Drug Retailing segment with no geographic diversification disclosed.
  • Free cash flow of SAR 465.1 million supports reinvestment and shareholder returns.
  • Analysts project moderate revenue growth of 4.5% in the current fiscal year.
  • The company faces moderate liquidity risk and low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$6.35B
Gross profit$2.17B
Operating income$395.7M
Net income$269.9M
R&D
SG&A
D&A
SBC
Operating cash flow$670.8M
CapEx-$161.4M
Free cash flow$465.1M
Total assets$6.14B
Total liabilities$4.61B
Total equity$1.53B
Cash & equivalents$13.7M
Long-term debt$2.83B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.53B
Net cash-$2.81B
Current ratio1.2
Debt/Equity1.9
ROA4.4%
ROE17.6%
Cash conversion2.5%
CapEx/Revenue-2.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric4161Activity
Op margin6.2%2.8% medp25 0.9% · p75 5.9%top quartile
Net margin4.3%1.8% medp25 0.3% · p75 3.6%top quartile
Gross margin34.1%24.1% medp25 13.8% · p75 31.4%top quartile
CapEx / revenue-2.5%-2.0% medp25 -3.8% · p75 -1.0%below median
Debt / equity185.0%56.0% medp25 14.0% · p75 113.8%top quartile
Observations
IR observations
Mean price target5.29 SAR
Median price target5.35 SAR
High price target5.88 SAR
Low price target4.50 SAR
Mean recommendation2.86 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count5.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate0.25 SAR
Last actual EPS0.24 SAR
Source: analysis-pipeline (hybrid)Generated: 2026-05-24 17:05 UTCJob: fde35c98